Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme 1 selected

Guidance programme

Showing 1 to 4 of 4 results for anaemia ckd

  1. Roxadustat for treating symptomatic anaemia in chronic kidney disease (TA807)

    Evidence-based recommendations on roxadustat (Evrenzo) for treating symptomatic anaemia associated with chronic kidney disease in adults.

    Technology appraisal guidance
    Published
    13 July 2022
    View recommendations

    Sections for TA807

  2. Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease [ID3821]

    In development [GID-TA10877] Expected publication date: 20 November 2024

    Technology appraisal guidance
    In development

  3. Daprodustat for treating anaemia in people with chronic kidney disease [ID3987]

    In development [GID-TA10886] Expected publication date: TBC

    Technology appraisal guidance
    In development

  4. Everolimus for preventing organ rejection in liver transplantation (TA348)

    Evidence-based recommendations on everolimus (Certican) for preventing organ rejection in adults having a liver transplant.

    Technology appraisal guidance
    Published
    22 July 2015
    View recommendations

    Sections for TA348